sparsentan will decrease the extent or effect of modafinil by affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Observe. Sparsentan (a CYP2C19 inducer) decreases publicity of CYP2C19 substrates and lessens efficacy related to these substrates. Wisor and Eriksson (2005) analyzed the results of modafinil in disorders of altered dopamine and norepinephrine https://judahnfsxz.blogzet.com/the-single-best-strategy-to-use-for-modafinil-40660640